• Something wrong with this record ?

Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

S. Delimpasi, MV. Mateos, HW. Auner, M. Gavriatopoulou, MA. Dimopoulos, H. Quach, H. Pylypenko, R. Hájek, X. Leleu, TK. Dolai, DK. Sinha, CP. Venner, R. Benjamin, MK. Garg, V. Doronin, Y. Levy, P. Moreau, Y. Chai, M. Arazy, J. Shah, S. Shacham,...

. 2022 ; 97 (3) : E83-E86. [pub] 20211229

Language English Country United States

Document type Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22010806

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010806
003      
CZ-PrNML
005      
20220506125755.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ajh.26434 $2 doi
035    __
$a (PubMed)34882831
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Delimpasi, Sosana $u General Hospital Evangelismos, Athens, Greece $1 https://orcid.org/0000000175237510
245    10
$a Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study / $c S. Delimpasi, MV. Mateos, HW. Auner, M. Gavriatopoulou, MA. Dimopoulos, H. Quach, H. Pylypenko, R. Hájek, X. Leleu, TK. Dolai, DK. Sinha, CP. Venner, R. Benjamin, MK. Garg, V. Doronin, Y. Levy, P. Moreau, Y. Chai, M. Arazy, J. Shah, S. Shacham, MG. Kauffman, PG. Richardson, S. Grosicki
650    _2
$a protokoly protinádorové kombinované chemoterapie $x aplikace a dávkování $7 D000971
650    _2
$a bortezomib $x aplikace a dávkování $7 D000069286
650    _2
$a dexamethason $x aplikace a dávkování $7 D003907
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hydraziny $x aplikace a dávkování $7 D006834
650    12
$a nemoci ledvin $x farmakoterapie $x mortalita $7 D007674
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mnohočetný myelom $x farmakoterapie $x mortalita $7 D009101
650    _2
$a míra přežití $7 D015996
650    _2
$a triazoly $x aplikace a dávkování $7 D014230
655    _2
$a dopisy $7 D016422
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mateos, Maria Victoria $u Hospital Universitario de Salamanca, Salamanca, Spain
700    1_
$a Auner, Holger W $u The Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College London, London, UK $1 https://orcid.org/0000000340400642
700    1_
$a Gavriatopoulou, Maria $u Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece $1 https://orcid.org/0000000262441229
700    1_
$a Dimopoulos, Meletios A $u School of Medicine, National and Kapodistrian University of Athens, Athens, Greece $1 https://orcid.org/0000000189903254
700    1_
$a Quach, Hang $u St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia
700    1_
$a Pylypenko, Halyna $u Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine
700    1_
$a Hájek, Roman $u Department of Hemato-oncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Leleu, Xavier $u Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France
700    1_
$a Dolai, Tuphan Kanti $u Nil Ratan Sircar Medical College and Hospital, Kolkata, India
700    1_
$a Sinha, Dinesh Kumar $u State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India
700    1_
$a Venner, Christopher P $u Cross Cancer Institute, Edmonton, Alberta, Canada $1 https://orcid.org/0000000347014285
700    1_
$a Benjamin, Reuben $u Kings College Hospital NHS Foundation Trust, London, UK
700    1_
$a Garg, Mamta Krishnan $u University Hospitals of Leicester NHS Trust, Leicester, UK
700    1_
$a Doronin, Vadim $u City Clinical Hospital #40, Moscow, Russian Federation
700    1_
$a Levy, Yair $u Baylor University Medical Center, Dallas, Texas, USA
700    1_
$a Moreau, Philippe $u University of Nantes, Nantes, France $1 https://orcid.org/0000000317808746
700    1_
$a Chai, Yi $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Arazy, Melina $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Shah, Jatin $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Shacham, Sharon $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Kauffman, Michael G $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Richardson, Paul G $u Dana-Farber Cancer Institute, Boston, Massachusetts, USA $1 https://orcid.org/0000000274268865
700    1_
$a Grosicki, Sebastian $u Medical University of Silesia, Katowice, Poland
773    0_
$w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 97, č. 3 (2022), s. E83-E86
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34882831 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125747 $b ABA008
999    __
$a ok $b bmc $g 1788767 $s 1162004
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 97 $c 3 $d E83-E86 $e 20211229 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options